Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Merck Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Elbasvir, Grazoprevir

Brand Name : ZEPATIER

Patent Number : 2756172

Filing Date : 2010-03-25

Strength per Unit : 50 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-03-25

Date Granted : 2015-11-24

blank

02

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Elbasvir, Grazoprevir

Brand Name : ZEPATIER

Patent Number : 2731177

Filing Date : 2009-07-17

Strength per Unit : 50 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-07-17

Date Granted : 2013-10-29

blank

03

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Elbasvir, Grazoprevir

Brand Name : ZEPATIER

Patent Number : 2667031

Filing Date : 2007-10-23

Strength per Unit : 50 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-10-23

Date Granted : 2013-01-22

blank